Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified (Gammaked, Gamunex-C)

Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified is an FDA-licensed reference biologic from Grifols Therapeutics LLC.

351(a) biologicBLA 125046 Grifols Therapeutics LLC
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2025

Reference product

Originator biologic
351(a)BLA 125046

Gammaked, Gamunex-C Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified

Grifols Therapeutics LLC

View full reference-product record
Approved
Marketing
Rx
Center
CBER
Patents
None listed

Exclusivity & patent cliffs

Protection horizon
  1. Orphan exclusivity ends

    7-year orphan-drug exclusivity window.

    11 yr 2 mo ago

  2. Reference approval

    Approval date of the reference Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified product.

    11 mo ago

Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.